🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate the clinical activity of the combination of flu...
Status
Active Not Recruiting
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Start Date
2019-07-29
Trial ID
NCT04005339
Treatments Being Tested
This phase I study is designed to determine the maximum tolerant dose of ca...
Status
Completed
Location
radiation department, Cancer Hospital, CAMS
Start Date
2011-01
Trial ID
NCT01584544
Treatments Being Tested
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT06998771
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
The investigators preliminary data suggests that FOLFOX-A may have equal or...
Status
Completed
Location
Roxanne Wood
Start Date
2014-02-01
Trial ID
NCT02022033
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
This trial is a Phase II study. All patients are resectable Gastric or Gast...
Status
Recruiting
Location
Tianjin Provincial Tumor Hospital
Start Date
2023-11-13
Trial ID
NCT05960955
Treatments Being Tested